Patient P-02215
Synthetic patientMETA-24 · Day 126 · 25–34 · F · baseline S07Steering view · 3DOpen companion preview
Therapy response
Improving
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
23%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S07
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- Inflammatory activity+10
- Toxicity+10
- Nutritional resilience+4
- Treatment adherence-4
- GI instability-2
What helped?
No interventions yet.
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable31 min
stable · +0.5 vs previous 14 d
Sleep duration
Wearable6.2 h
stable · -0.1 vs previous 14 d
Energy level
Daily log4.7/10
worsening · -0.3 vs previous 14 d
Steps
Wearable4,195
stable · +63 vs previous 14 d
GI burden
Companion26.8/100
stable · -0.1 vs previous 14 d
Adherence
Companion89.4 %
stable · -2.3 vs previous 14 d
Sleep quality
Wearable29.9/100
worsening · -2.6 vs previous 14 d
Glucose, CGM daily mean
CGM140 mg/dL
stable · +1.6 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards failing · 66 from the failing basin, 22 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -3.8 next day on high-intake days · n 22
- More fatGI -1.7 next day on high-intake days · n 20
Would not help
- Keep caffeine lowGI +3.6 next day on high-intake days · n 14
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-3.8supporter · 95%
- Caffeine+3.6detractor · 95%
- Dietary fat load-1.7supporter · 60%
- Alcohol+1.3no signal · 35%
- Simple carbohydrates-0.9no signal · 18%
- Ultra-processed food+0.6no signal · 20%
- Insoluble fibre+0.3no signal · 15%
- Histamine load-0.2no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Autonomic recovery ↓45
- WearableResting HR 74 bpm
- WearableShort sleep window
- Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
- Inflammatory signalling ↑15
- WearableHRV 30 ms, trending down
DNA
Fictional pharmacogenomic panel
- CYP2D6 Poor metabolizerHigher exposure at standard dose
Microbiome
Shannon diversity 3.6 · butyrate capacity 53/100
- Akkermansia muciniphilaNormal
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisNormal
- Bifidobacterium longumNormal
- EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 37 ms
- Sleep
- 6.4 h
- Steps
- 4,561
- Resting HR
- 74 bpm
Daily log: GI score 27, nutritional resilience 60, adherence 89.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- A 15-minute walk after lunch
- Protect a 7.5-hour sleep window; screens off 30 minutes before
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02518 | 45% | S17 | DT-01 | improved | 68 |
| P-02462 | 41% | S12 | DT-01 | improved | 65 |
| P-02354 | 40% | S01 | CR-01 | improved | 78 |
| P-02538 | 39% | S02 | GI-04 | improved | 59 |
| P-02698 | 38% | S06 | ME-01 | improved | 71 |
| P-02037 | 37% | S04 | GI-04 | improved | 53 |
| P-02274 | 37% | S15 | DT-01 | improved | 50 |
| P-02620 | 37% | S01 | HY-01 | improved | 64 |
| P-02126 | 36% | S16 | DT-01 | improved | 59 |
| P-02235 | 36% | S14 | DT-01 | improved | 50 |
| P-02339 | 36% | S03 | DT-01 | improved | 50 |
| P-02459 | 36% | S05 | HY-01 | improved | 52 |